{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:37:47Z","timestamp":1770741467627,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ijcard.2018.07.099","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T02:34:14Z","timestamp":1532140454000},"page":"74-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Cost effectiveness and clinical efficacy of patent foramen ovale closure as compared to medical therapy in cryptogenic stroke patients: A detailed cost analysis and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"273","author":[{"given":"Christopher A.","family":"Pickett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd C.","family":"Villines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon R.","family":"Resar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Hulten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.07.099_bb0005","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","article-title":"Prevalence of patent foramen ovale in patients with stroke","volume":"318","author":"Lechat","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.07.099_bb0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-117-6-461","article-title":"Patent foramen ovale as a risk factor for cryptogenic stroke","volume":"117","author":"Di Tullio","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2018.07.099_bb0015","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1056\/NEJMoa071422","article-title":"Patent foramen ovale and cryptogenic stroke in older patients","volume":"357","author":"Handke","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.07.099_bb0020","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMoa011503","article-title":"Patent foramen ovale and atrial septal aneurysm study group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both","volume":"345","author":"Mas","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.07.099_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(88)92944-3","article-title":"Patent foramen ovale in young stroke patients","volume":"2","author":"Webster","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0030","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","article-title":"Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study","volume":"105","author":"Homma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0035","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.amjcard.2014.08.027","article-title":"Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale","volume":"114","author":"Pickett","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2018.07.099_bb0040","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","article-title":"Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials","volume":"67","author":"Kent","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2018.07.099_bb0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.14503\/THIJ-13-3879","article-title":"Percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale: a meta-analysis of randomized controlled trials","volume":"41","author":"Pickett","year":"2014","journal-title":"Tex. Heart Inst. J."},{"issue":"8","key":"10.1016\/j.ijcard.2018.07.099_bb0050","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1212\/WNL.0000000000002961","article-title":"Practice advisory: recurrent stroke with patent foramen ovale (update of practice parameter): report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"87","author":"Mess\u00e9","year":"2016","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ijcard.2018.07.099_bb0055","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. Antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ijcard.2018.07.099_bb0060","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Gore REDUCE clinical study investigators. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"S\u00f8ndergaard","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ijcard.2018.07.099_bb0065","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.ijcard.2018.07.099_bb0070","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jama.1996.03540140060028","article-title":"The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine","volume":"276","author":"Russell","year":"1996","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.ijcard.2018.07.099_bb0075","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","article-title":"Recommendations of the panel on cost-effectiveness in health and medicine","volume":"276","author":"Weinstein","year":"1996","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.ijcard.2018.07.099_bb0080","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.1996.03540160061034","article-title":"Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine","volume":"276","author":"Siegel","year":"1996","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ijcard.2018.07.099_bb0085","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ijcard.2018.07.099_bb0090","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen Ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.07.099_bb0095","author":"Agency for Healthcare Research and Quality"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0100","author":"Food and Drug Administration"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0105","author":"Center for Medicare and Medicaid Services"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/CIRCOUTCOMES.110.957290","article-title":"Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding","volume":"3","author":"Amin","year":"2010","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ijcard.2018.07.099_bb0120","first-page":"2286","article-title":"Association of aspirin use with major bleeding in patients with and without diabetes","volume":"307","author":"De Bernardis","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.amjmed.2010.05.007","article-title":"Implications of the CHA(2)DS(2)-VASc and HAS-BLED scores for thromboprophylaxis in atrial fibrillation","volume":"124","author":"Lip","year":"2011","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2018.07.099_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1747-4949.2010.00535.x","article-title":"Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial","volume":"6","author":"Hankey","year":"2011","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0140","author":"Social Security Administration"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00019053-200321030-00004","article-title":"A meta-analysis of quality-of-life estimates for stroke","volume":"21","author":"Tengs TO","year":"2003","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0150","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1377\/hlthaff.19.2.92","article-title":"Are pharmaceuticals cost-effective? A review of the evidence","volume":"19","author":"Neumann","year":"2000","journal-title":"Health Aff."},{"key":"10.1016\/j.ijcard.2018.07.099_bb0155","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2018.07.099_bb0160","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.ijcard.2018.07.099_bb0165","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"295","author":"Peters","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0175","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","article-title":"Chapter 8: assessing risk of bias in included studies","author":"JPT","year":"2011"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0180","first-page":"e6","article-title":"Heart disease and stroke statistics--2013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0185","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ana.410250410","article-title":"Infarcts of undetermined cause: the NINCDS stroke data bank","volume":"25","author":"Sacco","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijcard.2018.07.099_bb0190","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1212\/WNL.0b013e318270401d","article-title":"Age at stroke: temporal trends in stroke incidence in a large, biracial population","volume":"79","author":"Kissela","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/B:HCMS.0000005396.69890.48","article-title":"The \u201cNICE\u201d approach to technology assessment: an economic perspective","volume":"7","author":"Birch","year":"2004","journal-title":"Health Care Manag. Sci."},{"issue":"16","key":"10.1016\/j.ijcard.2018.07.099_bb0210","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1001\/jama.283.16.2116","article-title":"Problems with the interpretation of pharmacoeconomic analyses, a review of submissions to the Australian Pharmaceutical Benefits Scheme","volume":"283","author":"Hill","year":"2000","journal-title":"J. Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.ijcard.2018.07.099_bb0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1524-4733.2001.43040.x","article-title":"Health economic guidelines \u2013 similarities, differences, and some implications","volume":"4","author":"Hjelmgren","year":"2001","journal-title":"Value Health"},{"key":"10.1016\/j.ijcard.2018.07.099_bb0220","series-title":"Congressional Research Service","article-title":"CRS report for Congress: comparative clinical effectiveness and cost-effectiveness research: background, history, and overview","author":"Jacobson","year":"2007"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318306260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318306260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T09:22:21Z","timestamp":1545902541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318306260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":42,"alternative-id":["S0167527318306260"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.07.099","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost effectiveness and clinical efficacy of patent foramen ovale closure as compared to medical therapy in cryptogenic stroke patients: A detailed cost analysis and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.07.099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}